Bitcoin Market Feels Ripple Effects of New Pharmaceutical Tariffs

A new round of tariffs on non-U.S. made pharmaceuticals has sparked volatility in the global market and is prompting speculation about how it might affect trade routes. The 100% tariff announced by former President Donald Trump aims to bolster domestic production through these measures, raising concerns about its impact on supply chains. While no immediate response from major U.S. pharmaceutical companies has been reported, industry experts anticipate shifts in supply chain strategies due to the uncertain environment.